DE602005021322D1 - An calciumbindende proteine - Google Patents

An calciumbindende proteine

Info

Publication number
DE602005021322D1
DE602005021322D1 DE602005021322T DE602005021322T DE602005021322D1 DE 602005021322 D1 DE602005021322 D1 DE 602005021322D1 DE 602005021322 T DE602005021322 T DE 602005021322T DE 602005021322 T DE602005021322 T DE 602005021322T DE 602005021322 D1 DE602005021322 D1 DE 602005021322D1
Authority
DE
Germany
Prior art keywords
binding proteins
reagent
preparation
calcium
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005021322T
Other languages
English (en)
Inventor
Varda Shoshan-Barmatz
Adrian Israelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHOSHAN BARMATZ VARDA
Original Assignee
SHOSHAN BARMATZ VARDA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHOSHAN BARMATZ VARDA filed Critical SHOSHAN BARMATZ VARDA
Publication of DE602005021322D1 publication Critical patent/DE602005021322D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4728—Calcium binding proteins, e.g. calmodulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0042—Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4727—Calcium binding proteins, e.g. calmodulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Catalysts (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602005021322T 2004-02-19 2005-02-17 An calciumbindende proteine Active DE602005021322D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL16049204A IL160492A0 (en) 2004-02-19 2004-02-19 Photoreactive compound specifically binding to calcium binding proteins
PCT/IL2005/000203 WO2005079155A2 (en) 2004-02-19 2005-02-17 Photoreactive compound specifically binding to calcium binding proteins

Publications (1)

Publication Number Publication Date
DE602005021322D1 true DE602005021322D1 (de) 2010-07-01

Family

ID=34073868

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005021322T Active DE602005021322D1 (de) 2004-02-19 2005-02-17 An calciumbindende proteine

Country Status (7)

Country Link
US (1) US8034314B2 (de)
EP (1) EP1722818B1 (de)
AT (1) ATE468139T1 (de)
CA (1) CA2556054A1 (de)
DE (1) DE602005021322D1 (de)
IL (1) IL160492A0 (de)
WO (1) WO2005079155A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL178494A0 (en) * 2006-10-05 2007-02-11 Univ Ben Gurion Fluorescent ruthenium compounds for detecting calcium binding proteins
KR101151800B1 (ko) 2009-02-04 2012-06-01 국민대학교산학협력단 칼슘 이온 검출용 센서
ES2885551T3 (es) * 2014-12-15 2021-12-14 Univ California Agentes antiarrítmicos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888248A (en) * 1986-07-01 1989-12-19 Hidefumi Hirai Colloidal metal dispersion, and a colloidal metal complex
DE19712530A1 (de) * 1997-03-25 1998-10-01 Boehringer Mannheim Gmbh Neue Monomerbausteine zur Markierung von peptidischen Nukleinsäuren
US20030144570A1 (en) * 1999-11-12 2003-07-31 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors
US6388001B1 (en) 1999-12-21 2002-05-14 General Electric Company Compounding filled silicone compositions

Also Published As

Publication number Publication date
WO2005079155A3 (en) 2005-12-15
WO2005079155A2 (en) 2005-09-01
IL160492A0 (en) 2004-07-25
CA2556054A1 (en) 2005-09-01
EP1722818A4 (de) 2008-08-13
EP1722818A2 (de) 2006-11-22
US20070298120A1 (en) 2007-12-27
EP1722818B1 (de) 2010-05-19
ATE468139T1 (de) 2010-06-15
US8034314B2 (en) 2011-10-11

Similar Documents

Publication Publication Date Title
MX2007002908A (es) Sondas inmovilizadas y metodos para detectar proteinas prionicas alteradas conformacionalmente.
CY1119412T1 (el) Μεθοδοι για την αξιολογηση μιας ανοσοαποκρισης σε εναν θεραπευτικο παραγοντα
MX2007008017A (es) Polipeptidos que se ligan a br3 y usos de los mismos.
NO20073981L (no) Criptobindende molekyler
BR112012007365A2 (pt) proteínas de ligação à il-1
UA96139C2 (uk) Антитіло до нейропіліну-1 (nrp1)
ATE553778T1 (de) Für humanes hepcidin spezifische antikörper
ATE504602T1 (de) Für humane matriptase spezifische bindungsproteine
DE60334460D1 (de) Antikörper spezifisch für das tau-protein des zentralen nervensystems
AU2006205900A8 (en) Methods and assays for distinguishing between different forms of diseases and disorders characterized by thrombocytopenia and/or by spontaneous interaction between Von Willebrand Factor (vWF) and platelets
ATE511645T1 (de) Testverfahren zum nachweis von antikörpern gegen lysosomenenzyme
DE602006007967D1 (de) Gegen das gemeinsame epitop von mutierten p53 gerichtete humane synthetische einzelkettenantikörper und anwendungen davon
Repalli et al. Screening strategies to identify HSP70 modulators to treat Alzheimer’s disease
WO2008034016A3 (en) Assays for detecting native-state proteins and identifying compounds that modulate the stability of native-state proteins
WO2004029072A3 (en) PrPsc -INTERACTING MOLECULES AND USES THEREOF
DE602006013143D1 (de) Verfahren zum nachweis aggregatbildender zirkulierender proteinformen und mittel zum einfangen gebildeter aggregate
Hu et al. Targeted dephosphorylation of tau by phosphorylation targeting chimeras (PhosTACs) as a therapeutic modality
DE602005021322D1 (de) An calciumbindende proteine
Wędzony et al. Potential roles of NCAM/PSA-NCAM proteins in depression and the mechanism of action of antidepressant drugs
BRPI0414365A (pt) composições, reagentes e kits para, e métodos de diagnosticar, monitorar e tratar obesidade e/ou diabetes
WO2005124358A3 (en) Diagnosis and treatment of siglec-6 associated diseases
DK2005190T4 (da) Inhibering af GASC1
MX2019012169A (es) Ensayos para evaluar la actividad de moduladores de miembros de la familia de hidroxiesteroide (17-beta) deshidrogenasa (hsd17b).
DK1051491T3 (da) Equin Fc Epsilon receptor-alfa-kæde-nukleinsyremolekyler, korresponderende proteiner og anvendelse heraf
EA025107B1 (ru) Способ диагностирования болезни альцгеймера, нейродегенерации при синдроме дауна или легкого когнитивного нарушения у субъекта (варианты) и набор для осуществления способа

Legal Events

Date Code Title Description
8364 No opposition during term of opposition